Piramal Pharma Limited

NSE PPLPHARMA.NS

Piramal Pharma Limited Revenue Per Share for the year ending March 31, 2024: USD 0.77

Piramal Pharma Limited Revenue Per Share is USD 0.77 for the year ending March 31, 2024, a 8.85% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Piramal Pharma Limited Revenue Per Share for the year ending March 31, 2023 was USD 0.71, a 109.36% change year over year.
Piramal Pharma Limited Revenue Per Share for the year ending March 31, 2022 was USD 0.34, a 2.40% change year over year.
Piramal Pharma Limited Revenue Per Share for the year ending March 31, 2021 was USD 0.33.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

NSE: PPLPHARMA.NS

Piramal Pharma Limited

CEO	Mr. Peter Daniel DeYoung
IPO Date	Oct. 19, 2022
Location	India
Headquarters	507, Skyline Wealth Space
Employees	6,719
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.

Key trends

Past 5 years